{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:29:43Z","timestamp":1769167783339,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpainsymman.2025.11.005","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:17:54Z","timestamp":1762539474000},"page":"e201-e204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of Nebulized Tranexamic Acid (TA) in Combination With Nebulized Recombinant Coagulation Factor VIIa to Treat Hemoptysis in Pediatric Patients With Cancer At End-Of-Life (EOL)"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6967-9216","authenticated-orcid":false,"given":"Santosh","family":"Yatam Ganesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5559-1720","authenticated-orcid":false,"given":"Nelda","family":"Itzep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8745-0412","authenticated-orcid":false,"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0001","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00408-024-00780-5","article-title":"Nebulized tranexamic acid in the management of hemoptysis: an integrative review","volume":"203","author":"Ye","year":"2025","journal-title":"Lung"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ppul.23497","article-title":"Etiologies of hemoptysis in children: a systematic review of 171 patients","volume":"52","author":"Simon","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0003","doi-asserted-by":"crossref","first-page":"1701813","DOI":"10.1183\/13993003.01813-2017","article-title":"Observational, multicentre study on the epidemiology of haemoptysis","volume":"51","author":"Mondoni","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0004","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.3390\/cancers15194765","article-title":"Hemoptysis in cancer patients","volume":"15","author":"Singer","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0005","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1089\/jpm.2015.0167","article-title":"Nebulized tranexamic acid as a noninvasive therapy for cancer-related hemoptysis","volume":"18","author":"Hankerson","year":"2015","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0006","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SPC.0000000000000154","article-title":"Management of respiratory symptoms in paediatric palliative care","volume":"9","author":"Craig","year":"2015","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0007","first-page":"CD005011","article-title":"Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia","volume":"2012","author":"Simpson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0008","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3345\/kjp.2016.59.3.105","article-title":"Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients","volume":"59","author":"Park","year":"2016","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0009","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/cc5132","article-title":"Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage","volume":"10","author":"Heslet","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0010","article-title":"Inhaled tranexamic acid As a novel treatment for pulmonary hemorrhage in critically ill pediatric patients: an observational study","volume":"2","author":"O\u2019Neil","year":"2020","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0011","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5144\/0256-4947.2015.231","article-title":"Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage","volume":"35","author":"Bafaqih","year":"2015","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0012","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","article-title":"Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial","volume":"154","author":"Wand","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0013","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jbiotec.2006.03.042","article-title":"Mechanism of action, development and clinical experience of recombinant FVIIa","volume":"124","author":"Hedner","year":"2006","journal-title":"J Biotechnol"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0014","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3109\/09537104.2013.835797","article-title":"Intrapulmonary rFVIIa for life threatening pulmonary hemorrhage in a case of relapsing acute lymphoblastic leukemia and platelet refractoriness","volume":"25","author":"Almomen","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-2561","article-title":"Off-label use of recombinant factor VIIa in pediatric patients","volume":"129","author":"McQuilten","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0016","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-140-6-200403160-00033","article-title":"Successful treatment of diffuse alveolar hemorrhage with activated factor VII","volume":"140","author":"Henke","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0017","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1542\/peds.2014-1782","article-title":"Intrapulmonary recombinant factor VIIa for diffuse alveolar hemorrhage in children","volume":"135","author":"Park","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1097\/01.ccm.0001100612.26991.42","article-title":"487: management of diffuse alveolar hemorrhage with nebulized tranexamic acid and recombinant factor viia","volume":"53","author":"Aliling","year":"2025","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0019","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/crj.13132","article-title":"Hemoptysis from the perspective of people with cystic fibrosis","volume":"14","author":"Roman","year":"2020","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jpainsymman.2009.04.027","article-title":"Management of terminal hemorrhage in patients with advanced cancer: a systematic literature review","volume":"38","author":"Harris","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0021","doi-asserted-by":"crossref","first-page":"S1069","DOI":"10.21037\/jtd.2017.06.41","article-title":"A systematic approach to the management of massive hemoptysis","volume":"9","author":"Radchenko","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0022","first-page":"399","article-title":"Tranexamic acid in patients with hemoptysis","volume":"85","author":"Tscheikuna","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jpainsymman.2025.11.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028921","article-title":"Inhaled opioids for cancer pain relief: a narrative review","volume":"101","author":"Osowicka","year":"2022","journal-title":"Medicine"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392425009327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392425009327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:38:15Z","timestamp":1767011895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392425009327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0885392425009327"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.11.005","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Nebulized Tranexamic Acid (TA) in Combination With Nebulized Recombinant Coagulation Factor VIIa to Treat Hemoptysis in Pediatric Patients With Cancer At End-Of-Life (EOL)","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}